Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients

Objective: To evaluate safety, tolerability and feasibility of long-term treatment with Granulocyte-colony stimulating factor (G-CSF), a well-known hematopoietic stem cell factor, guided by assessment of mobilized bone marrow derived stem cells and cytokines in the serum of patients with amyotrophic...

Descripción completa

Detalles Bibliográficos
Autores principales: Johannesen, Siw, Budeus, Bettina, Peters, Sebastian, Iberl, Sabine, Meyer, Anne-Louise, Kammermaier, Tina, Wirkert, Eva, Bruun, Tim-Henrik, Samara, Verena C., Schulte-Mattler, Wilhelm, Herr, Wolfgang, Schneider, Armin, Grassinger, Jochen, Bogdahn, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275232/
https://www.ncbi.nlm.nih.gov/pubmed/30534107
http://dx.doi.org/10.3389/fneur.2018.00971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275232/
https://www.ncbi.nlm.nih.gov/pubmed/30534107
http://dx.doi.org/10.3389/fneur.2018.00971

Ejemplares similares